ban the use of phenylpropanolamine in OTC products
November 2000
Experts are now urging the FDA to ban the use of phenylpropanolamine in OTC products.
This is due to a possible increased risk of hemorrhagic stroke in young women using appetite suppressants...and patients taking cough and cold products that contain phenylpropanolamine (PPA).
Caution patients not to exceed recommended doses of PPA-containing products...Acutrim, Dexatrim, Contac, Dimetapp, etc.
Get concise advice on drug therapy, plus unlimited access to CE
Pharmacist's Letter membership benefits include:
- 12 issues every year — what you need to know and do, right now
- Quick, practical reference charts and tools
- Comprehensive CE library to meet license renewal and state requirements
- Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
- Plus much more!
Choose the right tier for your needs today.
Already a subscriber? Log in
Volume pricing available. Get a quote